Skip Nav Destination
Issues
1 March 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1535-7163
EISSN 1538-8514
Issue Sections
ARTICLE
Targeting the platelet-derived growth factor receptor α with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeutic target
Nick Loizos; Yan Xu; Jim Huber; Meilin Liu; Dan Lu; Bridget Finnerty; Robin Rolser; Asra Malikzay; Anita Persaud; Erik Corcoran; Dhanvanthri S. Deevi; Paul Balderes; Rajiv Bassi; Xenia Jimenez; Christopher J. Joynes; Venkata R.M. Mangalampalli; Philipp Steiner; James R. Tonra; Yan Wu; Daniel S. Pereira; Zhenping Zhu; Dale L. Ludwig; Daniel J. Hicklin; Peter Bohlen; Larry Witte; Paul Kussie
Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling
James S. Hardwick; Yi Yang; Chunsheng Zhang; Bin Shi; Rosemary McFall; Elizabeth J. Koury; Susan L. Hill; Hongyue Dai; Robert Wasserman; Robert L. Phillips; Edward J. Weinstein; Nancy E. Kohl; Michael E. Severino; John R. Lamb; Laura Sepp-Lorenzino
Minireview
Correction
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.